Author:
Delbart Wendy,Ghanem Ghanem E.,Karfis Ioannis,Flamen Patrick,Wimana Zéna
Funder
Les Amis de l'Institut Bordet asbl
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine
Reference66 articles.
1. Overview and current status of peptide receptor radionuclide therapy;Bushnell;Surg Oncol Clin N Am,2020
2. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use;Reubi;Eur J Nucl Med,2000
3. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors;Strosberg;N Engl J Med,2017
4. Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors;Brabander;Clin Cancer Res Off J Am Assoc Cancer Res,2017
5. Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]Octreotate: toxicity, efficacy, and survival;Kwekkeboom;J Clin Oncol,2016
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献